A novel biologic platform elicits profound T cell costimulatory activity and antitumor immunity in mice

Overview of attention for article published in Cancer Immunology, Immunotherapy, January 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 22 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

EGFR binding molecules

Grant US-11629193-B2

United States of America

4-1BB AND OX40 BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS, ANTIBODIES AGAINST 4…

Application WO-2021030488-A1

World Intellectual Property Organisation (WIPO)

ANTIBODY MOLECULES THAT BIND CD137 AND OX40

Application WO-2020011966-A1

World Intellectual Property Organisation (WIPO)